Skip to main content
. 2024 Mar 6;9:62. doi: 10.1038/s41392-024-01782-8

Table 2.

Treatment-related AEs

Grade 1/2 Grade 3/4
Leukopenia 12 (55%) 2 (9%)
Neutropenia 7 (32%) 7 (32%)
Anemia 14 (64%) 1 (5%)
Thrombocytopenia 2 (9%) 1 (5%)
Hypofibrinogenemia 12 (55%) 4 (18%)
Prolonged activated partial thromboplastin time 10 (45%) 0
Hypoalbuminemia 15 (68%) 1 (5%)
Hyperbilirubinemia 16 (73%) 0
ALT elevation 9 (41%) 1 (5%)
AST elevation 11 (50%) 1 (5%)
Creatine 3 (14%) 0
Hyponatremia 11 (50%) 0
Hyperkalemia 7 (32%) 0
Serum amylase increased 3 (14%) 0
Hyperglycemia 3 (14%) 0
Hypertriglyceridemia 4 (18%) 1 (5%)
Hypothyroidism 8 (36%) 0
Nausea 5 (23%) 0
Vomiting 1 (5%) 0
Diarrhea 0 0
Mucositis 5 (23%) 0
Infection 0 0
Heart failure 0 1 (5%)